Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,000 shares at $109.65 ($783K) on 2026-08-17, disclosed to the SEC on 2026-08-17.
Scheduled sale ($783k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.65 | 900 | $99K | 12.6% |
| 2 | $110.52 | 300 | $33K | 4.2% |
| 3 | $112.01 | 3,320 | $372K | 47.5% |
| 4 | $112.56 | 2,480 | $279K | 35.7% |
| Total | $111.84 avg | 7,000 | $783K | 100% |
| Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |
| ORKA | SELL | 2026-05-15 | $433K | — | Filing → |